Skip to main content

Iterum Therapeutics plc

ITRMDelisted Jun 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001659323

Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Iterum Therapeutics plc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ITRM: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders25123−1
Shares317.9K133290.0K−27.8K (−8.7%)
Value$575.4K$215$243.7K−$331.5K (−57.6%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Iterum Therapeutics plc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ITRM in Q4 2022
InstitutionSharesValue% of portfolio
Virtu Financial LLC23,223$20.0K0.00%
Advisory Services Network, LLC78$660.00%
GWM Advisors LLC100$00.00%

Sold out (4)

Institutions that held Iterum Therapeutics plc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ITRM in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Jane Street Group, LLC30,479$49.0K
Grimes & Company, Inc.14,641$24.0K
Edmond de Rothschild Holding S.A.6,666$11.0K
Howe & Rusling Inc33$0

Not filed for Q4 2022 yet (1)

Institutions that held Iterum Therapeutics plc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITRM in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
American Portfolios Advisors133$215